Novel fabrication method creates aligned nanofiber hydrogels for tissue regeneration

The FDA on Fri­day con­vert­ed its ac­cel­er­at­ed ap­proval of John­son & John­son’s blad­der can­cer drug Balver­sa to a full ap­proval. Balver­sa, al­so known as erdafi­tinib,

The American Gastroenterological Association (AGA) endorsed the use of fecal microbiota-based therapies for recurrent Clostridioides difficile infections (CDIs) in new guideline recommendations, but advised against

En­do In­ter­na­tion­al, which lost a patent bat­tle last year over its va­so­pressin in­jec­tion Va­sostrict, is back in court — this time su­ing Zy­dus Phar­ma­ceu­ti­cals for